GlassScriptPhysician profile
Alfred A Demaria
NPI 1619085545
$4,017.03
in general payments reported to CMS, 2019-2025
40 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,873 · 2020: $1,144.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $475.30 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $337.53 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $303.52 | 2019-2020 | |
| Amgen INC. | $298.12 | 2019-2020 | |
| Livanova USA, INC. | $297.00 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $294.33 | 2019-2020 | |
| Allergan, INC. | $282.09 | 2019-2020 | |
| Eisai INC. | $279.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $132.53 | 2019 | |
| Avanir Pharmaceuticals, INC. | $128.01 | 2019 | |
| Emd Serono, INC. | $115.51 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $93.35 | 2019-2020 | |
| Lundbeck LLC | $90.99 | 2020 | |
| Aquestive Therapeutics, INC. | $86.87 | 2019 | |
| Grifols USA, LLC | $84.27 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $67.79 | 2019 | |
| Genzyme Corporation | $58.35 | 2019-2020 | |
| Acorda Therapeutics, INC | $56.67 | 2019-2020 | |
| Assertio Therapeutics, INC. | $54.77 | 2019 | |
| Greenwich Biosciences, INC. | $43.03 | 2019-2020 | |
| Aprecia Pharmaceuticals, LLC | $41.84 | 2020 | |
| Genentech USA, INC. | $36.89 | 2019 | |
| Mdd US Operations, LLC | $34.85 | 2019 | |
| Sk Life Science, INC. | $34.12 | 2020 | |
| Adamas Pharmaceuticals, INC. | $28.82 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $26.94 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.15 | 2020 | |
| Amneal Pharmaceuticals LLC | $25.42 | 2020 | |
| Zyla Life Sciences, INC. | $23.78 | 2019 | |
| Promius Pharma LLC | $22.59 | 2019 | |
| Biogen, INC. | $17.57 | 2019 | |
| Merz North America, INC. | $17.22 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.91 | 2020 | |
| Merck Sharp & Dohme LLC | $13.79 | 2020 | |
| Alnylam Pharmaceuticals INC. | $13.43 | 2020 | |
| Lilly USA, LLC | $13.13 | 2019 | |
| Harmony Biosciences LLC | $12.65 | 2020 | |
| Abbott Laboratories | $11.93 | 2019 | |
| Upsher-Smith Laboratories LLC | $11.19 | 2020 | |
| Pfizer INC. | $10.84 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Demaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.